Item 16. Form 10-K Summary.

4K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary.

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


		CVS HEALTH CORPORATION
Date:	February 10, 2026	By:	/s/ BRIAN O. NEWMAN
			Brian O. Newman
			Executive Vice President and Chief Financial Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


Signature	Title(s)	Date

/s/ FERNANDO AGUIRRE	Director	February 10, 2026
Fernando Aguirre

/s/ JEFFREY R. BALSER, M.D., Ph.D.	Director	February 10, 2026
Jeffrey R. Balser, M.D., Ph.D.

/s/ C. DAVID BROWN II	Director	February 10, 2026
C. David Brown II

/s/ JAMES D. CLARK	Senior Vice President - Controller and Chief	February 10, 2026
James D. Clark	Accounting Officer (Principal Accounting Officer)

/s/ ALECIA A. DECOUDREAUX	Director	February 10, 2026
Alecia A. DeCoudreaux

/s/ ROGER N. FARAH	Director	February 10, 2026
Roger N. Farah

/s/ ANNE M. FINUCANE	Director	February 10, 2026
Anne M. Finucane

/s/ J. DAVID JOYNER	President, Chief Executive Officer (Principal Executive	February 10, 2026
J. David Joyner	Officer), Chair of the Board and Director

/s/ J. SCOTT KIRBY	Director	February 10, 2026
J. Scott Kirby

/s/ MICHAEL F. MAHONEY	Director	February 10, 2026
Michael F. Mahoney

/s/ BRIAN O. NEWMAN	Executive Vice President and Chief Financial Officer	February 10, 2026
Brian O. Newman	(Principal Financial Officer)

/s/ LESLIE V. NORWALK	Director	February 10, 2026
Leslie V. Norwalk

/s/ LARRY M. ROBBINS	Director	February 10, 2026
Larry M. Robbins

/s/ GUY P. SANSONE	Director	February 10, 2026
Guy P. Sansone

/s/ DOUGLAS H. SHULMAN	Director	February 10, 2026
Douglas H. Shulman

Previous: Item 15. Exhibits, Financial Statement Schedules.